SBI Life Insurance Company Ltd will host an earnings conference call on July 24, 2026, at 16:30 IST to discuss its financial performance for the quarter ended June 30, 2026. The call is intended for analysts and investors to review the company's operational results during the period.

The company has provided specific dial-in details for participants joining from India and various international locations. Participants can also pre-register for the event to streamline access.

Conference Call Access Details

Participants wishing to pre-register can use the dedicated link provided by the Investor Relations Team. Following the event, an audio recording and a transcript of the earnings call will be made available on the company's official website. These materials will be hosted within the prescribed regulatory timelines to ensure compliance and accessibility for all stakeholders.

SBI Life Insurance has approved the grant of 8,94,910 stock options to eligible employees under its Employee Stock Option Scheme – 2018 (ESOS-2018). The decision was taken by the Board Nomination and Remuneration Committee during a meeting held on July 13, 2026. Each option granted will entitle the holder to one equity share of ₹10 upon exercise, aligning with the Securities and Exchange Board of India (SEBI) (Share Based Employees Benefits and Sweat Equity) Regulations, 2021.

The exercise price for these options will be determined based on the lower of the Fair Market Value (FMV) as on the grant date or the average FMV of the 15 trading days immediately preceding the grant date. This pricing mechanism ensures the options are issued at a fair valuation relative to market conditions.

Vesting and Exercise Schedule

The granted options follow a structured vesting schedule to incentivize long-term retention. Vesting will commence one year from the date of grant and will occur in three specific proportions over time.

The scheme is fully compliant with SEBI regulations, including Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. No options have been exercised, lapsed, or varied in terms at this stage, as confirmed by the disclosure. The filing was signed by Girish Manik, Company Secretary.